Nov 13, 2024, 16:00
Role of antibody drug conjugates in the treatment of patients with breast cancer brain metastases
Elisabetta Bonzano, Radiation Oncologist at Fondazione IRCCS Policlinico San Matteo and University of Pavia, shared an article by Stacey Pan on X:
“Role of antibody drug conjugates in the treatment of patients with breast cancer brain metastases.
This review aims to summarize the effectiveness of approved ADCs as well as promising new ADCs in development for breast cancer with BM.”
Role of antibody drug conjugates in the treatment of patients with breast cancer brain metastases.
Authors: Stacey Pan, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 15:56
Nov 13, 2024, 15:46
Nov 13, 2024, 15:32
Nov 13, 2024, 15:29
Nov 13, 2024, 15:25
Nov 13, 2024, 14:55